TABLE 3:
Differential Diagnoses of Pancreatic Sclerosing Epithelioid Mesenchymal Neoplasm
| Sclerosing Epithelioid Mesenchymal Neoplasm | Solid Pseudopapillary Neoplasms | Sarcomatoid Carcinomas of the Pancreas | Sclerosing Epithelioid Fibrosarcomas | Myoepithelial Neoplasms of Soft Tissue | Angiomatoid Fibrous Histiocytoma | Solitary Fibrous Tumor | Perivascular Epithelioid Cell Neoplasm (PEComa) | Leiomyosarcoma | Gastrointestinal Stromal Tumor | |
|---|---|---|---|---|---|---|---|---|---|---|
| Median Age | 40s | 20–30s | 50–60s | 50s | 40s | 10s-20s | 50s | 30s-40s | 60s | 60s |
| Gender | Female predominance | Female predominance | Female predominance | No gender predilection | No gender predilection | Slight female predominance | Female predominance | Female predominance | No gender predilection | Slight male predominance |
| Microscopic Features | Geographic apparence of hypo and hypercellular areas with collagenous stroma ("ropey collagen"); epithelioid to spindle cells with scant cytoplasm,round-oval nuclei and open chromatin; mild to moderate nuclear atypia | Variety of patterns (solid, pseudopapillary, cystic, trabecular, etc); small to medium-sized and polygonal to elongated cells with clear to eosinophilic cytoplasm and ovoid nuclei (often have grooves) | Sheets of spindle cells, sometimes with pleomorphic giant cells and/or heterologous elements | Hypo or hypercellular with large areas of hyalinized fibrous stroma; small to medium sized, uniform epithelioid cells with clear to scant eosinophilic cytoplasm and bland nuclei with vesicular or finely stipple chromatin | Often infiltrative with heterogenous morphology and myxoid or hyalinized stroma; epithelioid, spindled or plasmacytoid cells arranged in small nests, strands or file | Often highly cellular with sheets, short fascicles or whorls of bland spindle to ovoid eosinophilic cells | Spindle cells in a collagenous stroma ("ropey collagen") with irregularly distributed thick walled "staghorn" vessels | Nested, trabecular, or sheet-like architecture, sometime with a dense collagenous stroma; epithelioid and/or spindle cells with granular eosinophilic to clear cytoplasm | Interlacing spindle cells with varying degree of pleomorphism and atypia, necrosis; mitotic figures are common | Spindle cell, epithelioid or mixed morphology; extracellular collagen globules ("skeinoid fibres") may be seen; variable mitotic activity |
| Immunohistochemical Features | Vimentin, CD99 and cytokeratins (weak) | PR and abnormal B-catenin | Vimentin and cytokeratin (weak) | MUC4 | S100, cytokeratins, EMA | Desmin, SMA, CD68, CD99, EMA | CD34, Bcl2, nuclear STAT6 | Smooth muscle (SMA, desmin - less common) and melanocytic (HMB-45, Melan-A) markers | HHF35, SMA and desmin | CD117, DOG1, CD34 |
| Molecular Features | No recurrent somatic mutations, amplifications or deletions in any known oncogenes or suppressor genes; distinct methylation pattern | Somatic activating mutation in exon 3 of CTNNB1 | Oncogenic mutations of KRAS, and loss of function mutations and/or deletions of the tumor suppressor genes TP53, SMAD4/DPC4, CDKN2A/p16 | EWSR1-CREB3L1 or FUS-CREB3L21, FUS-CREB3L2 fusions | EWSR1-PBX1, EWSR1-POU5F1, EWSR1-ZNF44, FUS-KLF17 or EWSR1-KLF17 fusions | EWSR1-CREB1, EWSR1-ATF1, or FUS-ATF1 fusions | NAB2-STAT6 fusion | TSC1/ TSC2 mutations, SFPQ-TFE3, RAD51B-OPHN1, RAD51B -BRAGB fusions | Complex genotype; TP53 mutations common | Mutually exclusive activating mutations of KIT or PDGFRA receptor tyrosine kinases |